A Study To Compare Pregabalin/PF-00489791 Combination Versus Pregabalin Alone In Post-Herpetic Neuralgia
Status:
Completed
Trial end date:
2008-12-23
Target enrollment:
Participant gender:
Summary
Pregabalin is an alpha-2 delta ligand approved for the treatment of neuropathic pain,
however, not all patients will respond to this drug. This study will compare the efficacy of
pregabalin when administered with an experimental drug PF-00489791, in patients with
post-herpetic neuralgia. The efficacy of this combination will be compared to pregabalin
alone.